EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Impact of Mānuka Honey on Symptoms and Quality of Life in Individuals With Functional Dyspepsia: Protocol for a Feasibility Randomized Controlled Trial

Laura Ombasa iD, Jody Miller iD, Lara Ware iD, Holly Abbotts-Holmes iD, Jeffry Tang iD, Olivier Gasser iD, Karl Fraser iD, Simone Bayer iD, Roslyn Kemp iD, Rory Costello iD, Andrew Highton iD, Jackie Evans iD und 6 weitere

JMIR Research Protocols · 2025

DOI: 10.2196/66417 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Laura Ombasa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Nutrition, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Dyspepsia, Honey, Quality of Life, Leptospermum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional dyspepsia is a common gastrointestinal condition that reduces the quality of life and increases health care costs. The lack of well-defined causes limits effective treatments. Consumers report using mānuka honey to treat gastrointestinal symptoms, although clinical evidence supporting such use is limited. Preclinical studies suggest its unique bioactive compounds may reduce gastrointestinal inflammation. Recently, 3,6,7-trimethyllumazine (Lepteridine), a natural pteridine in mānuka honey, was shown to inhibit enzymes involved in gastrointestinal inflammation in in vitro studies. Therefore, Lepteridine-standardized mānuka honey may deliver digestive health benefits.

Objective

The aim of this feasibility study is to gather the data required to estimate sample size and support study logistics to design future trials. The primary objective will be preliminary assessments of the impact of Lepteridine-standardized mānuka honey on symptom severity and the quality of life in participants with mild-to-moderate functional dyspepsia. Other feasibility objectives include assessing the biological responses to mānuka honey standardized to medium and high levels of Lepteridine and measuring mānuka honey–derived metabolites in blood and urine.

Methods

This is a 3-arm, parallel, controlled, double-blind, randomized feasibility study. A total of 75 healthy adults with symptoms of functional dyspepsia (Rome IV criteria) and mild-to-moderate dyspepsia severity (Short Form Leeds Dyspepsia Questionnaire) were recruited between October 2022 and September 2023. Participants were randomized into one of three groups: (1) mānuka honey standardized to contain 10 mg/kg Lepteridine, (2) mānuka honey standardized to contain 40 mg/kg Lepteridine, or (3) honey maple flavored syrup control. After a 2-week lead-in period, participants consumed 10 g of allocated intervention twice daily for 6 weeks. Throughout the study, participants completed daily bowel movement diaries and validated weekly questionnaires about their gastrointestinal symptoms and quality of life. Stool samples and 3-day diet records were collected at baseline and the end of the intervention. Blood samples were collected at baseline, weeks 2 and 4, and at the end of the intervention. In addition, 6 healthy participants without symptoms of functional dyspepsia were recruited to undergo an acute 5-hour assessment for the appearance of Lepteridine and related metabolites in plasma and urine following consumption of Lepteridine-standardized mānuka honey. The study was approved by the Northern B Health and Disability Ethics Committee.

Results

Initial analysis includes 68 participants, with laboratory and data analyses being undertaken as of March 2024. The results of the primary and secondary outcomes will be published in peer-reviewed journals.

Conclusions

This study will provide essential information on the potential efficacy and suitability of Lepteridine-standardized mānuka honey for designing future clinical trials investigating its effect in treating symptoms of functional dyspepsia. Trial Registration Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12622001140741p; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384094 International Registered Report Identifier (IRRID) DERR1-10.2196/66417

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyspepsiaHoneyQuality of LifeLeptospermumHumansFeasibility StudiesDouble-Blind MethodAdultFemaleMaleMiddle AgedRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Lepteridinefeasibility protocolfunctional dyspepsiamānuka honeyquality of liferandomised controlled trial

Autor:innen und Institutionen

  • Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
  • Riddet Institute, Massey University, Palmerston North, New Zealand.
  • High-Value Nutrition National Science Challenge, Auckland, New Zealand.
  • Malaghan Institute of Medical Research, Wellington, New Zealand.
  • AgResearch, Palmerston North, New Zealand.
  • Department of Medicine, University of Otago, Christchurch, New Zealand.

ORCID-Profile: Laura Ombasa, Jody Miller, Lara Ware, Holly Abbotts-Holmes, Jeffry Tang, Olivier Gasser, Karl Fraser, Simone Bayer, Roslyn Kemp, Rory Costello, Andrew Highton, Jackie Evans, Troy Merry, Michael Schultz, Chris Frampton, Richard Gearry, Warren McNabb, Nicole Roy

Zitieren

APA

Ombasa, L., Miller, J., Ware, L., Abbotts-Holmes, H., Tang, J., Gasser, O., Fraser, K., Bayer, S., Kemp, R., Costello, R., Highton, A., Evans, J., Merry, T., Schultz, M., Frampton, C., Gearry, R., McNabb, W., & Roy, N. (2025). Impact of Mānuka Honey on Symptoms and Quality of Life in Individuals With Functional Dyspepsia: Protocol for a Feasibility Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/66417

Vancouver

Ombasa L, Miller J, Ware L, Abbotts-Holmes H, Tang J, Gasser O, et al. Impact of Mānuka Honey on Symptoms and Quality of Life in Individuals With Functional Dyspepsia: Protocol for a Feasibility Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/66417

BibTeX
@article{Ombasa2025,
  author = {Ombasa, Laura and Miller, Jody and Ware, Lara and Abbotts-Holmes, Holly and Tang, Jeffry and Gasser, Olivier and Fraser, Karl and Bayer, Simone and Kemp, Roslyn and Costello, Rory and Highton, Andrew and Evans, Jackie and Merry, Troy and Schultz, Michael and Frampton, Chris and Gearry, Richard and McNabb, Warren and Roy, Nicole},
  title = {Impact of Mānuka Honey on Symptoms and Quality of Life in Individuals With Functional Dyspepsia: Protocol for a Feasibility Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/66417}
}
Kostenlos starten →